Viewing StudyNCT06284317



Ignite Creation Date: 2024-05-06 @ 8:11 PM
Last Modification Date: 2024-10-26 @ 3:22 PM
Study NCT ID: NCT06284317
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-05
First Post: 2024-02-21

Brief Title: A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy Durvalumab and Surgery in Patients with Early-stage Operable Non-small Cell Lung Cancer
Sponsor: ETOP IBCSG Partners Foundation
Organization: ETOP IBCSG Partners Foundation

Conditions & Keywords Data

Conditions:
Name
Non Small Cell Lung Cancer
Keywords:
Name View
Durvalumab View
IIB-IIIB N2 resectable NSCLC View